Corbus Pharmaceuticals Holdings, Inc. Increase (Decrease) in Accounts Payable
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Increase (Decrease) in Accounts Payable of $2.94 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $4.81M, a 2648.57% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$1.87M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$564.00K, a 133.61% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$1.28M, a 165.37% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accounts payable for fiscal 2025 was -$2.35M, a 246.54% decline from fiscal 2024.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accounts payable for fiscal 2024 was $1.60M, a 55.93% increase from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accounts payable for fiscal 2023 was $1.03M.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$256.83K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.94M 10-Q · filed 2026-08-06 | $2.38M derived: sum of 3 quarters · filed 2026-08-06 | $1.10M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$1.87M 10-Q · filed 2026-05-12 | -$2.43M derived: sum of 2 quarters · filed 2026-05-12 | -$3.71M derived: sum of 3 quarters · filed 2026-05-12 | -$3.53M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$564.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$1.84M derived: sum of 2 quarters · filed 2026-03-09 | -$1.67M derived: sum of 3 quarters · filed 2026-08-06 | -$2.35M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | -$1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.10M derived: sum of 2 quarters · filed 2026-08-06 | -$1.78M 10-Q · filed 2025-11-12 | -$107.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $175.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$509.00K 10-Q · filed 2026-08-06 | $1.17M derived: sum of 3 quarters · filed 2026-08-06 | $3.12M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$684.00K 10-Q · filed 2026-05-12 | $994.00K derived: sum of 2 quarters · filed 2026-05-12 | $2.95M derived: sum of 3 quarters · filed 2026-05-12 | $2.05M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $3.63M derived: sum of 2 quarters · filed 2026-03-09 | $2.73M derived: sum of 3 quarters · filed 2026-03-09 | $1.60M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.06M derived: sum of 2 quarters · filed 2025-11-12 | -$75.00K 10-Q · filed 2025-11-12 | -$1.57M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | -$896.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$2.03M 10-Q · filed 2025-08-05 | -$3.53M derived: sum of 3 quarters · filed 2025-08-05 | -$335.00K derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | -$1.13M 10-Q · filed 2025-05-06 | -$1.13M 10-Q · filed 2024-05-07 | -$2.63M derived: sum of 2 quarters · filed 2025-05-06 | $561.00K derived: sum of 3 quarters · filed 2025-05-06 | $745.06K derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | -$1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $1.69M derived: sum of 2 quarters · filed 2025-03-11 | $1.88M derived: sum of 3 quarters · filed 2025-03-11 | $1.03M 10-K · filed 2025-03-11 | $1.03M 10-K · filed 2024-03-12 | |||
| 2023-09-30 | $3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.38M derived: sum of 2 quarters · filed 2024-11-07 | $2.53M 10-Q · filed 2024-11-07 | $2.53M 10-Q · filed 2023-11-07 | $3.51M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $184.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$664.00K 10-Q · filed 2024-08-06 | -$663.84K 10-Q · filed 2023-08-08 | $316.46K derived: sum of 3 quarters · filed 2024-08-06 | -$493.97K derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | -$848.06K 10-Q · filed 2024-05-07 | $132.40K derived: sum of 2 quarters · filed 2024-05-07 | -$678.02K derived: sum of 3 quarters · filed 2024-05-07 | -$1.67M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $980.46K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $170.03K derived: sum of 2 quarters · filed 2024-03-12 | -$822.14K derived: sum of 3 quarters · filed 2024-03-12 | -$256.83K 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | -$810.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$1.80M derived: sum of 2 quarters · filed 2023-11-07 | -$1.24M 10-Q · filed 2023-11-07 | -$2.00M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | -$992.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$426.87K 10-Q · filed 2023-08-08 | -$1.19M derived: sum of 3 quarters · filed 2023-08-08 | -$949.05K derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $565.31K 10-Q · filed 2023-05-09 | -$194.40K derived: sum of 2 quarters · filed 2023-05-09 | $43.12K derived: sum of 3 quarters · filed 2023-05-09 | -$1.70M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | -$759.71K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | -$522.19K derived: sum of 2 quarters · filed 2023-03-07 | -$2.26M derived: sum of 3 quarters · filed 2023-03-07 | -$5.96M 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $237.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$1.50M derived: sum of 2 quarters · filed 2022-11-08 | -$5.20M 10-Q · filed 2022-11-08 | -$9.12M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$5.43M 10-Q · filed 2022-08-09 | -$9.36M derived: sum of 3 quarters · filed 2022-08-09 | -$10.77M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$3.69M 10-Q · filed 2022-05-10 | -$7.62M derived: sum of 2 quarters · filed 2022-05-10 | -$9.03M derived: sum of 3 quarters · filed 2022-05-10 | -$6.32M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$3.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$5.34M derived: sum of 2 quarters · filed 2022-03-08 | -$2.63M derived: sum of 3 quarters · filed 2022-03-08 | -$3.47M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | -$1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.30M derived: sum of 2 quarters · filed 2021-11-12 | $458.65K 10-Q · filed 2021-11-12 | $5.66M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $2.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.87M 10-Q · filed 2021-08-12 | $7.07M derived: sum of 3 quarters · filed 2021-08-12 | $5.13M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$839.37K 10-Q · filed 2021-05-13 | $4.36M derived: sum of 2 quarters · filed 2021-05-13 | $2.43M derived: sum of 3 quarters · filed 2021-05-13 | $1.08M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $3.27M derived: sum of 2 quarters · filed 2021-03-15 | $1.92M derived: sum of 3 quarters · filed 2021-03-15 | $4.37M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | -$1.93M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-09 | -$3.29M derived: sum of 2 quarters · filed 2020-11-09 | -$836.30K 10-Q · filed 2020-11-09 | -$586.76K derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | -$1.35M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-31 | $1.10M 10-Q/A · filed 2020-08-31 | $1.35M derived: sum of 3 quarters · filed 2020-08-31 | $4.37M derived: sum of 4 quarters · filed 2020-08-31 | ||||
| 2019-03-31 | $2.45M 10-Q · filed 2020-05-11 | $2.70M derived: sum of 2 quarters · filed 2020-05-11 | $5.73M derived: sum of 3 quarters · filed 2020-05-11 | $5.16M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $249.54K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $3.28M derived: sum of 2 quarters · filed 2020-03-16 | $2.71M derived: sum of 3 quarters · filed 2020-03-16 | $3.90M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $2.46M derived: sum of 2 quarters · filed 2019-11-07 | $3.65M 10-Q · filed 2019-11-07 | $2.25M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | -$564.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $628.21K 10-Q · filed 2019-08-08 | -$775.26K derived: sum of 3 quarters · filed 2019-08-08 | -$847.01K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $1.19M 10-Q · filed 2019-05-09 | -$210.92K derived: sum of 2 quarters · filed 2019-05-09 | -$282.66K derived: sum of 3 quarters · filed 2019-05-09 | $306.57K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$1.48M derived: sum of 2 quarters · filed 2019-03-12 | -$885.99K derived: sum of 3 quarters · filed 2019-03-12 | -$885.80K 10-K · filed 2019-03-12 | ||||
| 2017-09-30 | -$71.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $517.49K derived: sum of 2 quarters · filed 2018-11-08 | $517.68K 10-Q · filed 2018-11-08 | $960.55K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $589.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $589.42K 10-Q · filed 2018-08-08 | $1.03M derived: sum of 3 quarters · filed 2018-08-08 | $1.84M derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2017-03-31 | $191.00 10-Q · filed 2018-05-10 | $443.06K derived: sum of 2 quarters · filed 2018-05-10 | $1.25M derived: sum of 3 quarters · filed 2018-05-10 | $2.09M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $442.87K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $1.25M derived: sum of 2 quarters · filed 2018-03-12 | $2.09M derived: sum of 3 quarters · filed 2018-03-12 | $1.89M 10-K · filed 2018-03-12 | ||||
| 2016-09-30 | $805.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.64M derived: sum of 2 quarters · filed 2017-11-08 | $1.45M 10-Q · filed 2017-11-08 | $2.04M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | $838.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $642.16K 10-Q · filed 2017-08-09 | $1.23M derived: sum of 3 quarters · filed 2018-03-12 | $689.30K derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | -$196.31K 10-Q · filed 2017-05-09 | -$196.65K 10-Q · filed 2016-05-13 | $392.04K derived: sum of 2 quarters · filed 2018-03-12 | -$149.16K derived: sum of 3 quarters · filed 2018-03-12 | $931.75K derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2015-12-31 | $588.35K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $47.14K derived: sum of 2 quarters · filed 2018-03-12 | $1.13M derived: sum of 3 quarters · filed 2018-03-12 | $972.19K 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | -$541.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $539.71K derived: sum of 2 quarters · filed 2016-11-10 | $383.85K 10-Q · filed 2016-11-10 | $245.35K derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $925.05K 10-Q · filed 2016-08-12 | $786.56K derived: sum of 3 quarters · filed 2016-08-12 | $1.07M derived: sum of 4 quarters · filed 2016-08-12 | ||||
| 2015-03-31 | -$155.86K 10-Q · filed 2016-05-13 | -$294.36K derived: sum of 2 quarters · filed 2016-05-13 | -$12.82K derived: sum of 3 quarters · filed 2016-05-13 | $6.93K derived: sum of 4 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | -$138.49K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $143.05K derived: sum of 2 quarters · filed 2016-03-28 | $162.79K derived: sum of 3 quarters · filed 2016-03-28 | $170.24K 10-K · filed 2016-03-28 | ||||
| 2014-09-30 | $281.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $301.29K derived: sum of 2 quarters · filed 2015-11-10 | $308.73K 10-Q · filed 2015-11-10 | $400.49K derived: sum of 4 quarters · filed 2015-11-10 | ||||
| 2014-06-30 | $19.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $27.19K 10-Q · filed 2015-08-13 | $118.94K derived: sum of 3 quarters · filed 2015-08-13 | |||||
| 2014-03-31 | $7.45K 10-Q · filed 2015-05-13 | $99.20K derived: sum of 2 quarters · filed 2015-05-13 | ||||||
| 2013-12-31 | $91.75K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10 | $131.85K 10-K · filed 2015-02-10 | ||||||
| 2013-09-30 | $40.10K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |